Activist 13D/13G Filings - ORBIMED ADVISORS LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...14, 15, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-05-22
7:32 pm
Unchanged
13DApollomics Inc.
APLM
ORBIMED ADVISORS LLC8,615,456
7.9%
0
(Unchanged)
View
2024-05-20
4:55 pm
Sale
13DEnliven Therapeutics Inc.
ELVN
ORBIMED ADVISORS LLC7,918,163
16.8%
-1,033,300decrease
(-11.54%)
View
2024-05-08
7:55 pm
Unchanged
13DCorvus Pharmaceuticals Inc.
CRVS
ORBIMED ADVISORS LLC6,943,654
11.1%
0
(Unchanged)
View
2024-04-12
5:35 pm
Unchanged
13DPassage BIO Inc.
PASG
ORBIMED ADVISORS LLC8,034,000
13%
0
(Unchanged)
View
2024-04-04
4:39 pm
Purchase
13DEnliven Therapeutics Inc.
ELVN
ORBIMED ADVISORS LLC8,951,463
19.2%
2,124increase
(+0.02%)
View
2024-03-28
4:28 pm
Purchase
13DQ32 BIO INC
QTTB
ORBIMED ADVISORS LLC2,252,987
18.9%
2,252,987increase
(New Position)
View
2024-03-22
4:59 pm
Unchanged
13DCOMPASS THERAPEUTICS INC
CMPX
ORBIMED ADVISORS LLC18,791,422
13.7%
0
(Unchanged)
View
2024-03-21
4:31 pm
Unchanged
13DAdicet Bio Inc.
ACET
ORBIMED ADVISORS LLC9,772,598
11.9%
0
(Unchanged)
View
2024-03-08
4:34 pm
Sale
13DNEXTCURE INC
NXTC
ORBIMED ADVISORS LLC1,268,013
4.5%
-1,443,000decrease
(-53.23%)
View
2024-02-21
4:11 pm
Unchanged
13DKinnate Biopharma Inc.
KNTE
ORBIMED ADVISORS LLC7,559,729
16.1%
0
(Unchanged)
View
2024-02-14
7:45 pm
Sale
13GALX ONCOLOGY HOLDINGS INC
ALXO
ORBIMED ADVISORS LLC2,255,000
4.5%
-11,000decrease
(-0.49%)
View
2024-02-14
7:41 pm
Purchase
13GInspireMD Inc.
NSPR
ORBIMED ADVISORS LLC2,133,405
9.9%
2,133,405increase
(New Position)
View
2024-02-14
7:36 pm
Purchase
13GX4 Pharmaceuticals Inc
XFOR
ORBIMED ADVISORS LLC11,494,437
6.7%
1,165,788increase
(+11.29%)
View
2024-02-14
7:31 pm
Purchase
13GVERASTEM INC
VSTM
ORBIMED ADVISORS LLC1,529,115
6.1%
1,529,115increase
(New Position)
View
2024-02-14
7:28 pm
Sale
13GSI-BONE Inc.
SIBN
ORBIMED ADVISORS LLC2,144,631
5.3%
-1,056,469decrease
(-33.00%)
View
2024-02-14
7:21 pm
Purchase
13GSCHOLAR ROCK HLDG CORP
SRRK
ORBIMED ADVISORS LLC2,960,000
4.1%
2,960,000increase
(New Position)
View
2024-02-14
7:11 pm
Sale
13GProtara Therapeutics Inc.
TARA
ORBIMED ADVISORS LLC0
0%
-671,741decrease
(Position Closed)
View
2024-02-14
7:00 pm
Sale
13GNeuroPace Inc
NPCE
ORBIMED ADVISORS LLC4,003,967
15.2%
-8,314decrease
(-0.21%)
View
2024-02-14
6:55 pm
Sale
13GMersana Therapeutics Inc.
MRSN
ORBIMED ADVISORS LLC0
0%
-7,082,837decrease
(Position Closed)
View
2024-02-14
6:51 pm
Sale
13GMereo BioPharma Group plc
MREO
ORBIMED ADVISORS LLC0
0%
-10,378,591decrease
(Position Closed)
View
Goto 0, 1, 2, ...14, 15, Next